Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 7, 2021
Important role of Nfkb2 in the Kras<sup>G12D</sup>-driven carcinogenesis in the pancreas
Zonera Hassan, Christian Schneeweis, Matthias Wirth, et al.
Molecular Cancer Therapeutics
|
November 26, 2025
The histone modifier KANSL2 is an actionable biomarker in multiple myeloma
Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg, et al.
Nature Communications
|
December 8, 2023
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis
Judith Dönig, Hannah Mende, Jimena Davila Gallesio, et al.
Cancer Communications (London, England)
|
March 7, 2022
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
Christian Schneeweis, Zonera Hassan, Katja Ascherl, et al.
Oncotarget
|
May 21, 2016
Membranous CD24 drives the epithelial phenotype of pancreatic cancer
Clara Lubeseder-Martellato, Ana Hidalgo-Sastre, Carolin Hartmann, et al.
United European Gastroenterology Journal
|
September 16, 2025
Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer
Jonas Buchloh, Melanie Spitzner, Hauke Zimmermann, et al.
The EMBO Journal
|
September 5, 2022
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma
Carmen Paulmann, Ria Spallek, Oleksandra Karpiuk, et al.
EMBO Molecular Medicine
|
July 24, 2023
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response
Le Zhang, Matthias Wirth, Upayan Patra, et al.
British Journal of Cancer
|
February 1, 2018
MTOR inhibitor-based combination therapies for pancreatic cancer
Zonera Hassan, Christian Schneeweis, Matthias Wirth, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 19, 2022
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
Christian Schneeweis, Sandra Diersch, Zonera Hassan, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 7, 2021
Important role of Nfkb2 in the Kras<sup>G12D</sup>-driven carcinogenesis in the pancreas
Zonera Hassan, Christian Schneeweis, Matthias Wirth, et al.
Molecular Cancer Therapeutics
|
November 26, 2025
The histone modifier KANSL2 is an actionable biomarker in multiple myeloma
Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg, et al.
Nature Communications
|
December 8, 2023
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis
Judith Dönig, Hannah Mende, Jimena Davila Gallesio, et al.
Cancer Communications (London, England)
|
March 7, 2022
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
Christian Schneeweis, Zonera Hassan, Katja Ascherl, et al.
Oncotarget
|
May 21, 2016
Membranous CD24 drives the epithelial phenotype of pancreatic cancer
Clara Lubeseder-Martellato, Ana Hidalgo-Sastre, Carolin Hartmann, et al.
United European Gastroenterology Journal
|
September 16, 2025
Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer
Jonas Buchloh, Melanie Spitzner, Hauke Zimmermann, et al.
The EMBO Journal
|
September 5, 2022
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma
Carmen Paulmann, Ria Spallek, Oleksandra Karpiuk, et al.
EMBO Molecular Medicine
|
July 24, 2023
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response
Le Zhang, Matthias Wirth, Upayan Patra, et al.
British Journal of Cancer
|
February 1, 2018
MTOR inhibitor-based combination therapies for pancreatic cancer
Zonera Hassan, Christian Schneeweis, Matthias Wirth, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 19, 2022
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
Christian Schneeweis, Sandra Diersch, Zonera Hassan, et al.
Page
of 7